Skip to content

Application of Ropivacaine Paravertebral Block Technique in Thoracoscopic Lobectomy under the Guidance of Estella Ketamine Combining with Ultrasound

Application of Ropivacaine Paravertebral Block Technique in Thoracoscopic Lobectomy under the Guidance of Estella Ketamine Combining with Ultrasound

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044003
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-04-01
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Group I:0.9% saline
GroupII:0.35% Ropivacaine
Group III:S-ketamine and 0.35% Ropivacaine

Sponsors

People's Hospital of Rizhao
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old (including 18 and 65 years old) , sex is not limited; 2. BMI18-25kg/m2; 3. Patients undergoing elective thoracoscopic lobectomy under general anesthesia; 4. ASA I-III level; 5. There was no history of chronic pain before operation, no complication of hypertension and heart disease, no serious lung infection and atelectasis, liver and kidney function were normal; 6. Patients who were fully aware of the purpose and significance of the trial, volunteered to participate.

Exclusion criteria

Exclusion criteria: 1. Patients who had undergone anesthesia or surgery in the first 7 days of the study, or who had had another thoracotomy 48 hours after the procedure, were randomized; 2. Patients with history of acute myocardial infarction and unstable Angina pectoris in 6 months before the screening period 3. Patients with severe hypertension (systolic blood pressure >= 160 MMHG, diastolic blood pressure >= 90 MMHG) or with hypotension (systolic blood pressure < 90 MMHG) without satisfactory control; 4. People with mental illness (such as schizophrenia, depression, etc.) or cognitive impairment; 5. People with a serious lung infection; 6. People with severe Coagulopathy; 7. People history of drug abuse, drug use; 8. The operation involved both sides; 9. The researchers concluded that there were any other conditions that were not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Time of complete ultrasound-guided Thoracic paravertebral nerve block;Blood pressure;Heart rate;Oxygenation;Visual Analogue Scale Score;Oxygenation;Visual Analogue Scale Score;Sensory nerve block segment;Press Times of PCIA;Postoperative agitation;Nausea;Vomitus;Respiratory depression;Pulmonary complications (pneumonia, atelectasis, pleural effusion, respiratory insufficiency);Patient satisfaction with analgesic effect;Depressive state before and after intervention;

Countries

China

Contacts

Public ContactWang Kai

People's Hospital of Rizhao

wangkaidoctor@163.com+86 18963312237

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026